The 4 analysts offering 12-month price forecasts for Akero Therapeutics Inc have a median target of 47.50, with a high estimate of 62.00 and a low estimate of 26.00. The median estimate represents a +403.18% increase from the last price of 9.44.
The current consensus among 4 polled investment analysts is to Buy stock in Akero Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.86
Reporting Date Aug 16
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.